"Designing Growth Strategies is in our DNA"

Silent Scan Technology Market Size, Share, and Industry Analysis, By Strength (1.5T and More than 1.5T), By Application (Musculoskeletal, Neurology, Cardiology, Body Imaging, and Others), By End User (Hospitals & ASCs and Diagnostic Centers), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI111698 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global silent scan technology market is witnessing significant growth owing to the increasing number of diagnostic procedures among patients resulting in rising R&D activities to develop and introduce technologically advanced magnetic resonance imaging machines integrated with silent scan technology in the market. Silent scan technology is designed to reduce MR scanner noise to near ambient sound levels, thereby improving the patient’s magnetic resonance exam experience.

  • According to a 2023 article published by the National Center for Biotechnology Information (NCBI), about 36.7 million magnetic resonance imaging scans are conducted each year in the U.S.

Silent Scan Technology Market Driver

Increasing MRI Procedures to Drive Market Growth

The increasing number of magnetic resonance procedures among the patient population is resulting in the growing focus of key layers towards the integration of technological advancements in MRI equipment globally, thereby supporting the growing adoption rate for these devices in the market.

  • According to the 2023 statistics published by the National Health Service (NHS), it was reported that about 4.1 million MRI scans were performed in the U.K.

Download Free sample to learn more about this report.

According to data published by the Organisation for Economic Co-operation and Development (OECD), it was reported that the number of MRI scans performed was 36.7 million in the U.S., 8.8 in France, 13.2 in Germany, and 14.2 in Japan.

Silent Scan Technology Market Restraint

High Costs Associated with Advanced MRI Equipment May Hinder Market Growth

There is a growing demand for advanced MRI equipment integrated with silent scan technology among healthcare providers. However, the rising cost of advanced magnetic resonance imaging equipment is likely to limit the demand for these products in the market.

  • According to 2024 statistics published by Excedr, it was reported that a new MRI scanner costs from USD 1.0 million to USD 3.0 million.

Silent Scan Technology Market Opportunity

Strategic Initiatives by Key Market Players to Provide Future Growth Prospects

The rising focus of key players toward acquisitions and mergers among the other players to strengthen their presence in the market, further resulting in the growing adoption and demand of advanced MRI systems globally.

  • In January 2024, GE Healthcare acquired MIM Software, a provider of medical imaging analysis and artificial intelligence solutions, to practice molecular radiotherapy, radiation oncology, diagnostic imaging, and urology at hospitals, imaging centers, research organizations, and specialty clinics.

Segmentation

By Strength

By Application

By End User

By Geography

  • 1.5T
  • More than 1.5T
  • Musculoskeletal
  • Neurology
  • Cardiology
  • Body Imaging
  • Others
  • Hospitals & ASCs
  • Diagnostic Centers
  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Prevalence of Key Disorders, By Key Countries, 2023
  • Annual MRI Scans, By Key Countries, 2023
  • Overview: Technological Advancements in Silent Scan Technology
  • Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches)
  • Impact of COVID-19 on the Market

Analysis by Type

Amongst type, the market is divided into 1.5T and more than 1.5T.

The 1.5T segment held a significant market share in 2023. The rising focus of key players toward the development and introduction of advanced MRI machines integrated with silent scan technology is likely to support the segmental growth.

  • In November 2021, Canon Medical launched advanced Vantage Fortian, a 1.5T MRI system integrated with deep learning reconstruction technology to remove noise and restore SNR to MRI images.

Analysis by Application

Based on application, the market is fragmented into musculoskeletal, neurology, cardiology, body imaging, and others.

The musculoskeletal segment accounted for a substantial share of the market in 2023. The segmental growth is due to the rising prevalence of musculoskeletal conditions, resulting in a growing number of diagnostic procedures, thereby supporting the increasing adoption rate of these products in the market.

  • According to 2022 data published by the World Health Organization (WHO), about 1.7 billion people have musculoskeletal disorders globally.

Analysis by End User

Amongst end user, the market is subdivided into hospitals & ASCs and diagnostic centers.

The hospital & ASCs segment accounted for a prominent market share in 2023. The growth is due to the increasing number of hospitals, further contributing to the rising adoption rate for magnetic resonance imaging (MRI) systems globally.

  • According to 2023 data published by the American Health Association (AHA), there are 6,120 hospitals in the U.S.

Regional Analysis

To gain extensive insights into the market, Download for Customization

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the largest share of the global silent scan technology market in 2023. The growth is due to several factors, such as the increasing number of MRI procedures, the increasing number of key players operating in the market, developed healthcare infrastructure, among others.

  • According to 2023 statistics published by the Canadian Agency for Drugs and Technologies in Health, about 2.2 million MRI scans were conducted in Canada.

Additionally, Europe is the second-largest market for silent scan technology. The increasing prevalence of acute and chronic disorders, such as musculoskeletal conditions, and others, is resulting in the rising demand for MRI machines globally. This, coupled with the growing focus of prominent players toward inorganic growth strategies, including acquisitions and mergers, among others, is further expected to support the market growth.

  • According to 2023 data published by Versus Arthritis, over 20 million people are living with musculoskeletal conditions in the U.K.

Asia Pacific is expected to grow at a considerable CAGR during the forecast period. The growth is owing to the rising number of prominent players offering advanced magnetic resonance imaging products in the market.

Key Players Covered

The global silent scan technology market is consolidated, with few players operating in the global silent scan technology market.

The report includes the profiles of the following key players:

  • GE Healthcare (U.S.)
  • Avotec Inc. (U.S.)
  • CANON MEDICAL SYSTEMS CORPORATION (Japan)
  • Hitachi High-Tech Corporation (Japan)
  • Siemens Healthineers (Germany)
  • United Imaging Healthcare Co., Ltd. (China)

Key Industry Developments

  • In October 2024, OrthTeam Centre launched Deep Resolve MRI technology, which is an advanced medical imaging technology that combines deep learning and AI techniques and provides reduced scan time, less noise, and decreased motion.
  • In June 2023, GE Healthcare showcased the integration of its advanced AIR technologies with the SIGNA PET/MR AIR system with an aim to enhance diagnostic precision and simplify treatment evaluation.


  • Ongoing
  • 2024
  • 2019-2023
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann